@article{fc5e3b9611ea4d608fff2fbef72ead2f,
title = "Enhancing slow oscillations and increasing N3 sleep proportion with supervised, non-phase-locked pink noise and other non-standard auditory stimulation during NREM sleep",
abstract = "Purpose: In non-rapid eye movement (NREM) stage 3 sleep (N3), phase-locked pink noise auditory stimulation can amplify slow oscillatory activity (0.5–1 Hz). Open-loop pink noise auditory stimulation can amplify slow oscillatory and delta frequency activity (0.5–4 Hz). We assessed the ability of pink noise and other sounds to elicit delta power, slow oscillatory power, and N3 sleep. Participants and Methods: Participants (n = 8) underwent four consecutive inpatient nights in a within-participants design, starting with a habituation night. A registered poly-somnographic technologist live-scored sleep stage and administered stimuli on randomized counterbalanced Enhancing and Disruptive nights, with a preceding Habituation night (night 1) and an intervening Sham night (night 3). A variety of non-phase-locked pink noise stimuli were used on Enhancing night during NREM; on Disruptive night, environmental sounds were used throughout sleep to induce frequent auditory-evoked arousals. Results: Total sleep time did not differ between conditions. Percentage of N3 was higher in the Enhancing condition, and lower in the Disruptive condition, versus Sham. Standard 0.8 Hz pink noise elicited low-frequency power more effectively than other pink noise, but was not the most effective stimulus. Both pink noise on the “Enhancing” night and sounds intended to Disrupt sleep administered on the “Disruptive” night increased momentary delta and slow-wave activity (ie, during stimulation versus the immediate pre-stimulation period). Disruptive auditory stimulation degraded sleep with frequent arousals and increased next-day vigilance lapses versus Sham despite preserved sleep duration and momentary increases in delta and slow-wave activity. Conclusion: These findings emphasize sound features of interest in ecologically valid, translational auditory intervention to increase restorative sleep. Preserving sleep continuity should be a primary consideration if auditory stimulation is used to enhance slow-wave activity.",
author = "Schade, {Margeaux M.} and Mathew, {Gina Marie} and Roberts, {Daniel M.} and Daniel Gartenberg and Buxton, {Orfeu M.}",
note = "Funding Information: Dr Margeaux M. Schade reports grants, non-financial support from Proactive Life Inc, formerly Mobile Sleep Technologies LLC (DBA SleepSpace)/NSF, during the conduct of the study; grants, non-financial support from Proactive Life Inc/NIH, outside the submitted work. Funding Information: Professor Orfeu Buxton reports grants from Proactive Life Inc, formerly Mobile Sleep Technologies LLC (DBA SleepSpace), during the conduct of the study; grants from Proactive Life Inc, outside the submitted work and Dr. Buxton reports current grant support from the National Institutes of Health (NIA, NIMH, NHLBI, NIMHD, NICHD, NIDDK, NCATS, NLM). Dr. Buxton received honoraria/travel support for lectures from Boston University, Boston College, Tufts School of Dental Medicine, and Allstate, and receives an honorarium from the National Sleep Foundation (sleepfoundation.org) for his work as Editor in Chief (designate) of Sleep Health. Funding Information: We would like to thank the participants for providing their data. Work was funded by the National Science Foundation (NSF) under grant #1622766, awarded to Gartenberg (PI; CEO Proactive Life Inc, formerly Mobile Sleep Technologies LLC (DBA SleepSpace)). Funding Information: Dr Daniel M. Roberts reports personal fees from Proactive Life Inc, formerly Mobile Sleep Technologies LLC (DBA SleepSpace), grants from National Institutes of Health, grants from National Science Foundation, during the conduct of the study. Funding Information: The current work was supported by the National Science Foundation (NSF) under grant #1622766 awarded to Gartenberg (PI; CEO Proactive Life Inc, formerly Mobile Sleep Technologies LLC (DBA SleepSpace)). Work was conducted at Pennsylvania State University (via subcontract) and further supported by the Pennsylvania State University Clinical and Translational Sciences Institute (funded by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002014) and institutional funds from the College of Health and Human Development of the Pennsylvania State University to Dr. Buxton. Collaboration also included a separate project: NIH/NIA SBIR R43AG056250 to Gartenberg (PI; CEO Proactive Life Inc) “Non-pharmacological improvement of sleep structure in midlife and older adults” via subcontract to Pennsylvania State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NSF or NIH. Funding Information: The current work was supported by the National Science Foundation (NSF) under grant #1622766 awarded to Gartenberg (PI; CEO Proactive Life Inc, formerly Mobile Sleep Technologies LLC (DBA SleepSpace)). Work was conducted at Pennsylvania State University (via subcon-tract) and further supported by the Pennsylvania State University Clinical and Translational Sciences Institute (funded by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002014) and institutional funds from the College of Health and Human Development of the Pennsylvania State University to Dr. Buxton. Collaboration also included a separate project: NIH/NIA SBIR R43AG056250 to Gartenberg (PI; CEO Proactive Life Inc) “Non-pharmacological improvement of sleep structure in midlife and older adults” via subcontract to Pennsylvania State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NSF or NIH. Publisher Copyright: {\textcopyright} 2020 Schade et al.",
year = "2020",
doi = "10.2147/NSS.S243204",
language = "English (US)",
volume = "12",
pages = "411--429",
journal = "Nature and Science of Sleep",
issn = "1179-1608",
publisher = "Dove Medical Press Ltd.",
}